Background Trials of endovascular therapy for ischemic stroke have produced variable
results. We conducted this study to test whether more advanced imaging selection, recently …

Background Trials of the efficacy and safety of endovascular thrombectomy in patients with
large ischemic strokes have been carried out in limited populations. Methods We performed a …

Background The time to initiate intravenous thrombolysis for acute ischemic stroke is generally
limited to within 4.5 hours after the onset of symptoms. Some trials have suggested that …

Background Intravenous infusion of alteplase is used for thrombolysis before endovascular
thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer …

Background: Early mobilisation after stroke is thought to contribute to the effects of stroke-unit
care; however, the intervention is poorly defined and not underpinned by strong evidence. …

Finding, testing and demonstrating efficacy of new treatments for stroke recovery is a
multifaceted challenge. We believe that to advance the field, neurorehabilitation trials need a …

Background Stroke thrombolysis with alteplase is currently recommended 0–4·5 h after
stroke onset. We aimed to determine whether perfusion imaging can identify patients with …

Together with numerous benefits that were brought about by the transition from the silo
enterprise perspective towards the process-based supply chain view of contemporary business, …

Background and Purpose— Regaining functional independence is an important goal for
people who have experienced stroke. We hypothesized that introducing earlier and more …

Hashimoto's thyroiditis (HT), the most frequent autoimmune thyroid disorders (AITDs), is the
leading cause of hypothyroidism in the iodine-sufficient areas of the world. About 20–30% of …